Abstract:OBJECTIVE:To investigate the effect of ovarian carcinoma cell on T cell JAK-STAT signal transduction pathway and its role in the ovarian carcinoma induced immunosupression. METHODS:Human ovarian carcinoma cells of OVCAR3. CAOV3, and SKOV3 lines were cultured. CD8(+) T cells were isolated from the peripheral venous blood of healthy persons. Then the supernatants of these ovarian carcinoma cell lines and RPMI-1640 were added into the culture of CD8(+) T cells (groups I, II, III, and control). Thiazolyl blue (MTT) method was used to detect the growth of CD8(+) T cell. The cell cycle was examined by flow cytometry. The secretion of the Tc1 type cytokine interferon (IFN)-gamma mRNA and the secretion of the Tc2 type cytokine interleukin (IL)-10 mRNA were detected by RT-PCR. The expression of signaling molecules JAK and JAK3 and the phosphorylated activation of STAT3 and STAT5 in the CD8(+) T cell were analyzed by Western blotting. RESULTS:The absorbance at the wavelength 570 nm of CD8(+) T cell culture was 0.23 +/- 0.03, 0.28 +/- 0.06, and 0.29 +/- 0.05 in the group I, II, and III, all significantly lower than that in the group IV (0.79 +/- 0.07, all P < 0.01). The percentages of CD8(+) T cells at the stage S and stage G(2)/M were lower, and those in stage G(1)/G(0) were higher in groups I, II, and III than in group IV (all P < 0.01). The IFN-gamma expression was significantly lower in groups I, II, and III in comparison with that in group IV. However, the expression of IL-10 was significantly higher in groups I, II, and III in comparison with that in group IV. The expression of JAK3 protein, but not JAK1 protein, was significantly lower in groups I, II, and III in comparison with that in group IV. The phosphorylated activation of STAT5 was suppressed significantly in groups I, II, and III, whereas the phosphorylated activation of STAT3 was suppressed only in group I. CONCLUSION:Ovarian carcinoma may suppress T cell proliferation through inhibition of the JAK-STAT signal transduction pathway, which may be a mechanism of ovarian carcinoma induced immunosuppression.

Experimental study on ovarian cancer immunotherapy by EpCAM activated dendritic cells induce antigen-specific CD8+ cytotoxic T lymphocytes

Ovarian Carcinoma Cell Supernatants Inhibit Proliferation and IL-2R Expression of CD8~+ T Cell

In vitro anti-tumor effect of cytotoxicity T lymphocytes activated by dendritic cells loaded with freeze-thaw ovarian carcinoma antigen

Overexpression of the epithelial cell adhesion molecule is associated with a more favorable prognosis and response to platinum-based chemotherapy in ovarian cancer

Targeting myeloid cells in the tumor microenvironment enhances vaccine efficacy in murine epithelial ovarian cancer

Ovarian caremoma cell supernatants inhibit proliferation and IL-2R expression of CD8+ T cell

Human Epithelial Ovarian Carcinoma Cell-Derived Cytokines Cooperatively Induce Activated Cd4+Cd25-Cd45ra+Naive T Cells To Express Forkhead Box Protein 3 And Exhibit Suppressive Ability In Vitro

Chimeric Antigen receptor-T (CAR-T) cells targeting Epithelial cell adhesion molecule (EpCAM) can inhibit tumor growth in ovarian cancer mouse model

Effect of targeted ovarian cancer immunotherapy using ovarian cancer stem cell vaccine

[Tumor-Infiltrating Dendritic Cells in Epithelial Ovarian Carcinoma and Correlation with the Expression of Vascular Endothelial Growth Factor].

[Ovarian carcinoma cell inhibits T cell JAK-STAT signal transduction pathway, an experimental study].

Ovarian Carcinoma Cells Effectively Inhibit Differentiation and Maturation of Dendritic Cells Derived from Hematopoietic Progenitor Cells in Vitro

Efficacy of Bispecific Antibody Targeting EpCAM and CD3 for Immunotherapy in Ovarian Cancer Ascites: An Experimental Study

EpCAM Signaling Promotes Tumor Progression and Protein Stability of PD-L1 through the EGFR Pathway

Immunogenicities of Apoptotic Ovarian Cancer Cells Induced by Paclitaxel Combined with Cisplatin

An in vitro investigation into the cytotoxic impact of antigen-presenting dendritic cell-tumor infiltrating lymphocytes on ovarian cancer cells

THE IMMUNOHISTOCHEMICAL STUDY OF DENDRITIC CELL PHENOTYPIC ANTIGENS IN HUMAN OVARIAN EPITHELIAL CARCINOMA

DC-derived CXCL10 promotes CTL activation to suppress ovarian cancer

Study on the Mesothelin-Specific Cytotoxicity Against Epithelial Ovarian Cancer with Full-Length Mesothelin Cdna-Transduced Dendritic Cells.

EpCAM peptide-primed dendritic cell vaccination confers significant anti-tumor immunity in hepatocellular carcinoma cells

Dendritic Cell Vaccines in Ovarian Cancer